Trial site
Shandong Public Health Clinical Center
- 12running trials
- 6closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Hepatitis B7 trials
- Tuberculosis4 trials
- Liver cirrhosis2 trials
- Lung cancer2 trials
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 26 trials
- Phase 34 trials
- Phase 42 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Completed6 trials
- Not yet recruiting4 trials
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Beijing 302 Hospital1 trial
- Beijing Kawin Technology Share-Holding Co., Ltd.1 trial
- Beijing Protgen Biotechnology Development Co., Ltd.1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- and 12 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
BRIGHT-Child TB: Short-Course Treatment for Non-Severe Pulmonary Tuberculosis in Children
Recruiting
Recruiting
A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets
Recruiting
Recruiting
Not yet recruiting
Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis
Recruiting
Fufang Congrong Yizhi Capsules (FCYC) of Cognitive Impairment After Intracerebral Hemorrhage
Recruiting
Recruiting
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Recruiting
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Tuberculosis4 recruiting
- Hepatitis B3 recruiting
- Lung cancer2 recruiting
- Colorectal cancer1 recruiting
- Coronary artery disease1 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Completed
Completed
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Completed
Completed
Completed
Completed
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
Site data: ClinicalTrials.govUpdated 19 Nov 2026